Eva Hadaschik

Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series

S1‐Guideline Sebaceous Carcinoma

Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma

Early versus late response to PD-1-based immunotherapy in metastatic melanoma

Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomas

S1‐Leitlinie Talgdrüsenkarzinom

Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM

Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma

Characterisation and outcome of RAC1 mutated melanoma

Regulatory T-cell deficiency leads to features of autoimmune liver disease overlap syndrome in scurfy mice

Prognostic factors in the primary care of patients with Merkel cell carcinoma: A monocentric cohort study of 108 patients from a tertiary referral centre

1168P Tumor PD-L1 predicts the outcome of PD-1-based immunotherapy in metastatic melanoma depending on the type of tissue examined

S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid

Genetic characterization of advanced conjunctival melanoma and response to systemic treatment

S2k‐Leitlinie zur Diagnostik und Therapie des Schleimhautpemphigoids

Impaired Treg-DC interactions contribute to autoimmunity in leukocyte adhesion deficiency type 1

Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors

Clinical and pathological characteristics of familial melanoma with germline <scp><i>TERT</i></scp> promoter variants

Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions

NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors

Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study

Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic Melanoma

TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy

Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition – Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry

S1‐Guideline Cutaneous Angiosarcomas – Update 2021

Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology

Tumor PD-L1 expression and gene panel mutational profile as outcome predictors of PD-1-based checkpoint inhibition therapy in metastatic melanoma: A prospective multicenter DeCOG study.

Covid-19 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up - a monocenter study

Response to comment – Molecular pathology as a diagnostic aid in difficult to classify melanocytic tumours with spitzoid morphology

Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis